Online Exclusives

Online Exclusives

Rollbacks on Telehealth Regulations Lead to Concerns Over Billing Fraud

The Centers for Medicare and Medicaid Services (CMS) unveiled a plan to promote widespread use of telehealth, which was previously limited to rural areas,...

To Fight COVID-19, Doctors Experiment with Alternatives to Ventilators

Fear of ventilator shortages has encouraged experimentation for workable alternatives, like repurposed sleep apnea machines. While combatting shortages is one goal, there is also...

FDA Approves Investigative New Drug Application for AUTO1 CAR-T Therapy for ALL

The FDA has accepted the Investigational New Drug (IND) application of CD19-targeting chimeric antigen receptor (CAR) T-cell therapy AUTO1 for the treatment of adults...

Global Vaccination Efforts Halted Amid Coronavirus Pandemic

The World Health Organization (WHO) warned that continuing global vaccination campaigns, which involve health workers going door-to-door or large groups gathering in one location...

Trump Administration Will Require Insurers to Provide Free Antibody Tests

The Trump administration has announced it will require health insurers to provide free antibody tests to detect potential immunity against coronavirus. Insurance providers will...

U.S. Pharma Executives Unknowingly Carried COVID-19 Across Several States and Countries

Earlier this year, Biogen employees unwittingly spread coronavirus across five states, the District of Columbia, and three countries. Senior executives were exposed to the...

White House Bans Hospitals From Sending Surprise Medical Bills for COVID-19 Treatment

As a requirement for receiving funds under the $2 trillion stimulus bill, hospitals cannot send surprise medical bills to patients treated for COVID-19, the...

Trump Administration Declines Re-Opening Obamacare Enrollment

The Trump administration has announced it will not be launching an Affordable Care Act (ACA) special enrollment period amid the COVID-19 pandemic. In recent...

Outpatient CAR T-Cell Therapy Appears Feasible for Patients With Large B-Cell Lymphoma

According to an analysis of three studies evaluating lisocabtagene maraleucel (liso-cel) presented at the 2020 Transplantation & Cellular Therapy Meetings, treatment with the outpatient...

Apixaban Noninferior to Subcutaneous Dalteparin for Cancer-Associated VTE

Results from the CARAVAGGIO trial showed the direct oral anticoagulant apixaban was as effective as dalteparin, a type of low-molecular-weight heparin, in preventing recurrent...
Advertisement

Current Issue

May 2020, Volume 6, Issue 6

This issue discusses AI's potential to improve patient care, debates using donors with clonal hematopoiesis for alloHCT, and more.